Clinical Trials Update: Jan. 6, 2004
Amyotrophic Lateral Sclerosis (ALS) Mantle Cell Lymphoma Anemia
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
Amyotrophic Lateral Sclerosis (ALS)
A research study to test the safety, tolerability, and effectiveness of an investigational medication in patients with amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease). Volunteers 21 to 80 who have a confirmed diagnosis of ALS may be eligible. Research site located in Kansas City, Kan.
Mantle Cell Lymphoma
A research study of an investigational medication for Mantle Cell Lymphoma. Volunteers at least 18 or older who have documented relapsed or refractory Mantle Cell Lymphoma following at least 1 or more prior therapies and who have adequate organ function may be eligible. Research site located in Iowa City, Iowa.
An experimental study for treating anemia in cancer subjects. Volunteers 18 or older who have anemia resulting from cancer, chemotherapy, or radiotherapy, who are stable for 1 month before the study starts and have a life expectancy of 9 months or greater based on the judgment of the investigator may be eligible. Research site located in Jamaica, NY.
Copyright 2004 CenterWatch. All rights reserved.